Condition
Allergic Sensitisation
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04186949Completed
Early Origins of Allergy and Asthma
NCT03815981Completed
Siderophore-profile in Allergic and Non-allergic Subjects
NCT03872219Not ApplicableUnknown
Biodiversity Intervention and Atopic Sensitization
NCT03251157Completed
Dietary Intake in Adults From the GA2LEN Folow-up Survey
Showing all 4 trials